At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 300 enrolled
Drug / intervention
Intravenous ibuprofendrug
Likely dose
Intravenous ibuprofen 800 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multi-Center, Open-Label, Surgical Surveillance Trial To Evaluate The Safety And Efficacy Of A Shortened Infusion Time of Intravenous Ibuprofen
In Brief
A Phase 4 clinical trial evaluating Intravenous ibuprofen for Pain. Completed, enrolled 300 participants across 22 sites.
Detailed Summary
The primary objective of this study is to determine the safety of a single dose of intravenous ibuprofen administered over 5-10 minutes for the preemptive treatment of postoperative pain.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedApr 2011
Enrollment StartJun 2011
Primary CompletionDec 2012
Study CompletionJan 2013
TodayJul 2026
First PostedApr 13, 2011
Enrollment StartJun 1, 2011
Primary CompletionDec 1, 2012
Study CompletionJan 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 15.2 years ago
Interventions
Intravenous ibuprofendrug
800 mg intravenous ibuprofen administered intravenously over 5-10 minutes